KUALA LUMPUR (April 9): The government will decide on whether Malaysia can continue to use the AstraZeneca Covid-19 vaccine or not in the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) meeting in two weeks’ time.
Coordinating Minister for the National Covid-19 Immunisation Programme Khairy Jamaluddin said during the meeting, the government will scrutinise any additional information to be tabled by the panel of experts from the Ministry of Health (MoH) before making any decision.
He said the government took note of the report from the European Medicines Agency (EMA) which confirmed for the first time that there is a link between the use of the AstraZeneca vaccine and blood clotting cases.
“In this case, before the announcement [by the EMA], our stance was as stated by Health Minister Datuk Seri Dr Adham Baba two days ago that we will proceed with the AstraZeneca vaccine.
“However, I think the safest approach is to refer back to JKJAV based on recent information that we have obtained from the EMA,” he told reporters after the launch of the CHAMPS-NASOM Autism Awareness Campaign 2021 here today.
Featured Videos
